Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biostage Inc (NASDAQ:BSTG)

1.01
Delayed Data
As of 1:21pm ET
 +0.037 / +3.78%
Today’s Change
0.53
Today|||52-Week Range
3.47
-53.44%
Year-to-Date
No recent news for Biostage Inc.

Today’s Trading

Previous close0.98
Today’s open0.97
Day’s range0.93 - 1.04
Volume84,289
Average volume (3 months)194,414
Market cap$16.7M
Dividend yield--
Data as of 1:21pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)+25.53%
Earnings growth (this year)+18.10%
Earnings growth (next 5 years)--
Revenue growth (last year)+26.88%
P/E ratioNM
Price/Sales206.07
Price/Book1.66

Competitors

 Today’s
change
Today’s
% change
MRICMRI Interventions In...-0.80-11.59%
AKERAkers Biosciences In...-0.06-1.68%
NEPHNephros Inc+0.06+15.65%
DHRMDehaier Medical Syst...-0.05-2.99%
Data as of 1:17pm ET, 08/30/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$118.0K
Annual profit (last year)-$11.7M
Net profit margin-9,918.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
James J. McGorry
Director-Quality &
Operations
Ginger A. Abraham-Freel
Corporate headquarters
Holliston, Massachusetts

Forecasts

Search for Jobs